From AI-driven vaccine candidate selection to the mass roll-out of virtual consultations, digital transformation is accelerating at an unprecedented rate in the face of COVID-19.
Artificial intelligence (AI) has now moved beyond its initial hype towards becoming a key part of the pharma industry – with many companies looking to partner with AI drug discovery start-u
The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.
So, what is this thing we call ‘empathetic technology’? While the two terms seem like antonyms, the intersection is proving to be a rich opportunity for innovation.
Artificial intelligence (AI) and machine learning (ML) are transforming the way cancers are detected and staged, offering new hope to the millions of people affected by the diseases every y